These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 23834475)
1. Degradation of MSCRAMM target macromolecules in VLU slough by Lucilia sericata chymotrypsin 1 (ISP) persists in the presence of tissue gelatinase activity. Pritchard DI; Brown AP Int Wound J; 2015 Aug; 12(4):414-21. PubMed ID: 23834475 [TBL] [Abstract][Full Text] [Related]
2. Wound debridement potential of glycosidases of the wound-healing maggot, Lucilia sericata. Telford G; Brown AP; Rich A; English JS; Pritchard DI Med Vet Entomol; 2012 Sep; 26(3):291-9. PubMed ID: 22620282 [TBL] [Abstract][Full Text] [Related]
3. Degradation of eschar from venous leg ulcers using a recombinant chymotrypsin from Lucilia sericata. Telford G; Brown AP; Seabra RA; Horobin AJ; Rich A; English JS; Pritchard DI Br J Dermatol; 2010 Sep; 163(3):523-31. PubMed ID: 20491762 [TBL] [Abstract][Full Text] [Related]
4. Expression of a cGMP compatible Lucilia sericata insect serine proteinase debridement enzyme. Pritchard DI; Telford G; Diab M; Low W Biotechnol Prog; 2012; 28(2):567-72. PubMed ID: 22323388 [TBL] [Abstract][Full Text] [Related]
5. Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Chambers L; Woodrow S; Brown AP; Harris PD; Phillips D; Hall M; Church JC; Pritchard DI Br J Dermatol; 2003 Jan; 148(1):14-23. PubMed ID: 12534589 [TBL] [Abstract][Full Text] [Related]
6. A Jonah-like chymotrypsin from the therapeutic maggot Lucilia sericata plays a role in wound debridement and coagulation. Pöppel AK; Kahl M; Baumann A; Wiesner J; Gökçen A; Beckert A; Preissner KT; Vilcinskas A; Franta Z Insect Biochem Mol Biol; 2016 Mar; 70():138-47. PubMed ID: 26773746 [TBL] [Abstract][Full Text] [Related]
7. Maggots as a wound debridement agent for chronic venous leg ulcers under graduated compression bandages: A randomised controlled trial. Davies CE; Woolfrey G; Hogg N; Dyer J; Cooper A; Waldron J; Bulbulia R; Whyman MR; Poskitt KR Phlebology; 2015 Dec; 30(10):693-9. PubMed ID: 25300315 [TBL] [Abstract][Full Text] [Related]
8. Evidence of Intensive Autolytic Debridement With a Self-Adaptive Wound Dressing. Reyzelman AM; Vartivarian M Wounds; 2015 Aug; 27(8):229-35. PubMed ID: 26284377 [TBL] [Abstract][Full Text] [Related]
9. Blow fly Lucilia sericata nuclease digests DNA associated with wound slough/eschar and with Pseudomonas aeruginosa biofilm. Brown A; Horobin A; Blount DG; Hill PJ; English J; Rich A; Williams PM; Pritchard DI Med Vet Entomol; 2012 Dec; 26(4):432-9. PubMed ID: 22827809 [TBL] [Abstract][Full Text] [Related]
10. Recombinant Lucilia sericata chymotrypsin in a topical hydrogel formulation degrades human wound eschar ex vivo. Britland S; Smith A; Finter W; Eagland D; Vowden K; Vowden P; Telford G; Brown A; Pritchard D Biotechnol Prog; 2011; 27(3):870-4. PubMed ID: 21509949 [TBL] [Abstract][Full Text] [Related]
11. Maggot chymotrypsin I from Lucilia sericata is resistant to endogenous wound protease inhibitors. Telford G; Brown AP; Kind A; English JS; Pritchard DI Br J Dermatol; 2011 Jan; 164(1):192-6. PubMed ID: 21175562 [TBL] [Abstract][Full Text] [Related]
12. [Biosurgical débridement using Lucilia sericata-maggots - an update]. Nenoff P; Herrmann A; Gerlach C; Herrmann J; Simon JC Wien Med Wochenschr; 2010 Dec; 160(21-22):578-85. PubMed ID: 20714816 [TBL] [Abstract][Full Text] [Related]
13. [Lucifensin, Chymotrypsin Proteins and Molecular Characterization of Lucilia sericata]. Erdoğan E; Karaca S Mikrobiyol Bul; 2021 Jan; 55(1):81-90. PubMed ID: 33590983 [TBL] [Abstract][Full Text] [Related]
14. Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor. Linger RJ; Belikoff EJ; Yan Y; Li F; Wantuch HA; Fitzsimons HL; Scott MJ BMC Biotechnol; 2016 Mar; 16():30. PubMed ID: 27006073 [TBL] [Abstract][Full Text] [Related]
15. [Comparative study of the efficacy of larva therapy for debridement and control of bacterial burden compared to surgical debridement and topical application of an antimicrobial]. Contreras-Ruiz J; Fuentes-Suárez A; Arroyo-Escalante S; Moncada-Barron D; Sosa-de-Martínez MC; Maravilla-Franco E; Domínguez-Cherit JG Gac Med Mex; 2016 Oct; 152(Suppl 2):78-87. PubMed ID: 27792719 [TBL] [Abstract][Full Text] [Related]
16. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon interactions between human dermal fibroblasts and extracellular matrix components. Horobin AJ; Shakesheff KM; Woodrow S; Robinson C; Pritchard DI Br J Dermatol; 2003 May; 148(5):923-33. PubMed ID: 12786822 [TBL] [Abstract][Full Text] [Related]
17. Wound care in venous ulcers. Mosti G Phlebology; 2013 Mar; 28 Suppl 1():79-85. PubMed ID: 23482540 [TBL] [Abstract][Full Text] [Related]
18. Endotoxin testing of a wound debridement device containing medicinal Lucilia sericata larvae. Pickles SF; Pritchard DI Wound Repair Regen; 2017 May; 25(3):498-501. PubMed ID: 28419727 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of methicillin-resistant Staphylococcus aureus (MRSA) as part of biosurgical management of a chronic leg ulcer]. Dissemond J; Koppermann M; Esser S; Schultewolter T; Goos M; Wagner SN Hautarzt; 2002 Sep; 53(9):608-12. PubMed ID: 12207265 [TBL] [Abstract][Full Text] [Related]
20. Maggot debridement therapy in chronic wound care. Chan DC; Fong DH; Leung JY; Patil NG; Leung GK Hong Kong Med J; 2007 Oct; 13(5):382-6. PubMed ID: 17914145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]